Abstract 160: Impact of Medication Adherence on Risk of Stroke, Major Bleeding and Other Outcomes in Atrial Fibrillation Patients Using Novel Oral Anticoagulants (Dabigatran and Rivaroxaban) [Session Title: Poster Session II]
Conclusion: In our sample, adherence to NOACs was associated with a reduction in stroke and DVTPE risk but did not substantially increase bleeding risk. Further studies with newer NOACs are warranted.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Deshpande, C. G., Willey Temkin, C., Laforge, R., Kogut, S. Tags: Session Title: Poster Session II Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Clinical Trials | Coumadin | Databases & Libraries | Heart | Ischemic Stroke | Pradaxa | Pulmonary Thromboembolism | Stroke | Study | Thrombosis | Warfarin